AVE avecho biotechnology limited

Terumo and Propofol Injectable, page-3

  1. 3,254 Posts.
    lightbulb Created with Sketch. 743
    MS
    Well spotted
    In my opinion this profotol patent is all POH scientist's own work without any Terumo input at this time.
    To support this view I can highlight the following:
    1.The applicant is Phosphagenics only and the inventor is an employee of Phosphagenics. The old POH company address is quoted in the document.
    2.The priority date for Australia is 9/12/2015.
    3.The priority date for the US is 28/4/2016 which is the day before the Terumo/Phosphagenics R&D research agreement was signed.
    4.When the Terumo R&D research agreement was signed it was indicated in that announcement that POH had already developed a profotol prototype product.
    Kens
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
-0.001(10.0%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $2.55K 511.1K

Buyers (Bids)

No. Vol. Price($)
26 18250625 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 27692966 23
View Market Depth
Last trade - 12.03pm 25/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.